[Effect of endogenous peptides on the status of mediator systems and compensation of motor disorders in parkinsonism].
Dambinova
S A
SA
Gurchin
F A
FA
Shevchenko
K A
KA
Gromov
I A
IA
D006801:Humans; D008875:Middle Aged; D008970:Molecular Weight; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D010455:Peptides / Q000627:therapeutic use*
D018377:Neurotransmitter Agents; D010455:Peptides